LU82818A1 - Compositions pharmaceutiques pour nutrition parenterale - Google Patents
Compositions pharmaceutiques pour nutrition parenterale Download PDFInfo
- Publication number
- LU82818A1 LU82818A1 LU82818A LU82818A LU82818A1 LU 82818 A1 LU82818 A1 LU 82818A1 LU 82818 A LU82818 A LU 82818A LU 82818 A LU82818 A LU 82818A LU 82818 A1 LU82818 A1 LU 82818A1
- Authority
- LU
- Luxembourg
- Prior art keywords
- carnitine
- glucose
- pharmaceutical compositions
- acyl
- compositions according
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT5046779 | 1979-10-05 | ||
IT50467/79A IT1120033B (it) | 1979-10-05 | 1979-10-05 | Composizione farmaceutica comprendente-carnitina adatta per l'alimentazione parenterale |
Publications (1)
Publication Number | Publication Date |
---|---|
LU82818A1 true LU82818A1 (fr) | 1981-02-02 |
Family
ID=11273028
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LU82818A LU82818A1 (fr) | 1979-10-05 | 1980-10-02 | Compositions pharmaceutiques pour nutrition parenterale |
Country Status (13)
Country | Link |
---|---|
US (1) | US4320145A (it) |
JP (1) | JPS5661310A (it) |
AT (1) | AT395111B (it) |
BE (1) | BE885527A (it) |
CA (1) | CA1154678A (it) |
CH (1) | CH641675A5 (it) |
DE (1) | DE3037479A1 (it) |
FR (1) | FR2468371A1 (it) |
GB (1) | GB2059262B (it) |
IL (1) | IL61190A (it) |
IT (1) | IT1120033B (it) |
LU (1) | LU82818A1 (it) |
NL (1) | NL8005450A (it) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3026368A1 (de) * | 1980-07-11 | 1982-02-18 | Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München | Naehrloesung fuer die vollstaendige parenterale ernaehrung und fuer gesteigerte energieproduktion |
IT1157238B (it) * | 1982-10-29 | 1987-02-11 | Sigma Tau Ind Farmaceuti | Impiego di 1-carnitina per migliorare i paramenti biochimici e comportamentali dell'eta' senile |
JP2518636B2 (ja) * | 1987-02-13 | 1996-07-24 | 雪印乳業株式会社 | 重症感染症及び広範囲熱症治療経腸栄養剤 |
FR2635264B1 (fr) * | 1988-08-12 | 1992-02-28 | Bellon Labor Sa Roger | Compositions pharmaceutiques et/ou dietetiques contenant de la l-carnitine et de la l-lysine |
IT1245869B (it) * | 1991-06-05 | 1994-10-25 | Sigma Tau Ind Farmaceuti | Impiego di propionil l-carnitina per il recupero del tono muscolare in soggetti immobilizzati |
US5256697A (en) * | 1992-04-16 | 1993-10-26 | Abbott Laboratories | Method of administering pyruvate and methods of synthesizing pyruvate precursors |
IT1263004B (it) * | 1992-10-08 | 1996-07-23 | Sigma Tau Ind Farmaceuti | Impiego della l-carnitina e acil l-carnitine nel trattamento a lungo termine di pazienti diabetici non insulino-dipendenti. |
IT1291127B1 (it) * | 1997-04-01 | 1998-12-29 | Sigma Tau Ind Farmaceuti | Integratore alimentare per soggetti dediti ad intensa e prolungata attivita' fisica |
DK1220670T3 (da) * | 1999-10-11 | 2006-12-18 | Sigma Tau Ind Farmaceuti | Anvendelse af L-carnitin og dets alkanoylderivater som osmotiske stoffer i oplösninger til medicinsk anvendelse |
IT1316998B1 (it) * | 2000-03-02 | 2003-05-26 | Sigma Tau Healthscience Spa | Composizione per la prevenzione e/o il trattamento degli effetticitotossici indotti dall'uso di agenti immunosoppressori. |
US6649176B1 (en) | 2000-06-29 | 2003-11-18 | Johnson & Johnson Consumer Companies, Inc. | Compositions containing mineral water |
US6630175B1 (en) | 2000-06-29 | 2003-10-07 | Johnson & Johnson Consumer Companies, Inc. | Method of reducing eye irritation |
US6372791B1 (en) | 2000-06-29 | 2002-04-16 | Johnson & Johnson Consumer Companies, Inc. | Method of promoting skin cell metabolism |
US6432424B1 (en) | 2000-06-29 | 2002-08-13 | Johnson & Johnson Consumer Companies, Inc. | Cosmetic compositions containing creatine, carnitine, and/or pyruvic acid |
GB0306394D0 (en) * | 2003-03-20 | 2003-04-23 | Univ Nottingham | Carnitine retention |
US20050232911A1 (en) * | 2004-04-19 | 2005-10-20 | Schreiber Brian D | Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid |
ITRM20040346A1 (it) * | 2004-07-13 | 2004-10-13 | Sigma Tau Ind Farmaceuti | Uso della l-carnitina per il trattamento di patologie cardiovascolari. |
US20060105972A1 (en) | 2004-11-17 | 2006-05-18 | Nagasawa Herbert T | Method to enhance delivery of glutathione and ATP levels in cells |
TW201201712A (en) * | 2010-01-28 | 2012-01-16 | Max International Llc | Compositions comprising sugar-cysteine products |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE639532A (it) * | ||||
FR3707M (fr) * | 1963-11-05 | 1965-11-22 | Belge Produits Chimiques Sa | Association de la carnitine a des émulsions lipidiques. |
US3810994A (en) * | 1972-06-01 | 1974-05-14 | Ethyl Corp | Method and composition for treating obesity |
US3968241A (en) * | 1972-11-06 | 1976-07-06 | Defelice Stephen L | Method of treating cardiac arrhythmias and of improving myocardial contractility and systolic rhythm with carnitive or a pharmaceutically acceptable salt thereof |
US3830931A (en) * | 1972-11-06 | 1974-08-20 | Felice S De | Carnitine and its use in the treatment of arrhythmia and impaired cardiac function |
AU518617B2 (en) * | 1977-04-29 | 1981-10-08 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Therapeutic application of acetyl-d, 1-carnitine |
JPS5460236A (en) * | 1977-10-21 | 1979-05-15 | Mitsubishi Electric Corp | Etching method |
IT1156741B (it) * | 1978-05-15 | 1987-02-04 | Sigma Tau Ind Farmaceuti | Applicazione terapeutica della carnitina e di alcuni derivati acilati della carnitina nell'emodialisi |
IT1156769B (it) * | 1978-05-25 | 1987-02-04 | Sigma Tau Ind Farmaceuti | Applicazione terapeutica della carnitina e di altri acil derivati della carnitina |
IT1116037B (it) | 1979-04-23 | 1986-02-10 | Sigma Tau Ind Farmaceuti | Esteri e ammidi di acil carnitine loro procedimenti di preparazione e loro uso terapeutico |
DE2921852A1 (de) * | 1979-05-29 | 1980-12-11 | Fresenius Chem Pharm Ind | Lipide senkendes mittel |
DE3026368A1 (de) * | 1980-07-11 | 1982-02-18 | Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München | Naehrloesung fuer die vollstaendige parenterale ernaehrung und fuer gesteigerte energieproduktion |
-
1979
- 1979-10-05 IT IT50467/79A patent/IT1120033B/it active
-
1980
- 1980-09-25 CA CA000361026A patent/CA1154678A/en not_active Expired
- 1980-09-26 CH CH722980A patent/CH641675A5/it not_active IP Right Cessation
- 1980-09-29 US US06/191,959 patent/US4320145A/en not_active Expired - Lifetime
- 1980-09-30 IL IL61190A patent/IL61190A/xx not_active IP Right Cessation
- 1980-10-01 GB GB8031646A patent/GB2059262B/en not_active Expired
- 1980-10-01 NL NL8005450A patent/NL8005450A/nl not_active Application Discontinuation
- 1980-10-02 LU LU82818A patent/LU82818A1/fr unknown
- 1980-10-03 BE BE0/202328A patent/BE885527A/fr not_active IP Right Cessation
- 1980-10-03 FR FR8021235A patent/FR2468371A1/fr active Granted
- 1980-10-03 DE DE19803037479 patent/DE3037479A1/de active Granted
- 1980-10-04 JP JP13923180A patent/JPS5661310A/ja active Granted
- 1980-10-06 AT AT0495580A patent/AT395111B/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
GB2059262A (en) | 1981-04-23 |
FR2468371B1 (it) | 1984-05-04 |
IL61190A0 (en) | 1980-11-30 |
FR2468371A1 (fr) | 1981-05-08 |
NL8005450A (nl) | 1981-04-07 |
DE3037479A1 (de) | 1981-05-21 |
ATA495580A (de) | 1985-03-15 |
CH641675A5 (it) | 1984-03-15 |
CA1154678A (en) | 1983-10-04 |
IT7950467A0 (it) | 1979-10-05 |
JPS5661310A (en) | 1981-05-26 |
GB2059262B (en) | 1983-11-09 |
DE3037479C2 (it) | 1988-09-08 |
IT1120033B (it) | 1986-03-19 |
IL61190A (en) | 1984-06-29 |
BE885527A (fr) | 1981-02-02 |
AT395111B (de) | 1992-09-25 |
US4320145A (en) | 1982-03-16 |
JPS643847B2 (it) | 1989-01-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LU82818A1 (fr) | Compositions pharmaceutiques pour nutrition parenterale | |
FR2907011A1 (fr) | Utilisation de la citrulline pour le traitement des etats de denutrition | |
FR2654932A1 (fr) | Composition anorexigene. | |
EP0862423A1 (fr) | Composition pharmaceutique pour administration par voie orale | |
FR2760972A1 (fr) | Utilisation de l-citrulline en medecine orthomoleculaire pour la vasoprotection, le tonus relaxatif des muscles lisses et la protection cellulaires | |
FR2981544A1 (fr) | Produit dietetique destine a la prevention du risque cardiometabolique | |
CH683067A5 (fr) | Composition pour augmenter l'activité renfermant de la tyrosine et un médicament sympathomimétique. | |
CA2435484A1 (fr) | Association medicamenteuse d'une biguanine et d'un transporteur, par exemple de metformine et d'arginine | |
WO1994012193A1 (fr) | Combinaison de cisplatine avec l'oxaliplatine | |
EP0655244B2 (fr) | Composition à base d'acides aminés pour le traitement d'infections | |
LU82013A1 (fr) | Nouvelles poudres lyophilisees contenant un sel de l'acide thiazolidine-4-carboxylique et leur procede de preparation | |
FR3007985A1 (fr) | Medicament pour la prevention et le traitement des facteurs de risques cardiometaboliques, en particulier maladies cardiovasculaires, pre-diabete, diabete de type ii et steatose hepatique | |
BE1023090B1 (fr) | Composition | |
WO1987003810A1 (fr) | Compositions nutritionnelles carencees en methionine et supplementee en homocysteine | |
EP3624822B1 (fr) | Principe actif constitue par un melange de composes poly-lysine et utilisation dans la prevention des avc et le traitement de la phase inflammatoire post-avc | |
EP3046552A1 (fr) | Composition intervenant dans la regulation du dysfonctionnement des cycles de l'energie, de l'inflammation et de l'insulinoresistance et son utilisation notamment dans les maladies cardiometaboliques | |
FR2922109A1 (fr) | Composition pharmaceutique ou dietetique pour inhiber l'absorption intestinale du sucre. | |
BE898124A (fr) | Composition pharmaceutique pour le traitement de la sénilité et son utilisation. | |
CA3157656A1 (fr) | Utilisation de nictotinamide mononucleotide (nmn) pour la prevention et/ou le traitement de la polyarthrite rhumatoide et compositions correspondantes | |
WO2002009740A1 (fr) | Composition contenant une proteine complexant le fer et un precurseur du metabolisme du monoxyde d'azote et/ou un donneur chimique de monoxyde d'azote et utilisations | |
US20060105965A1 (en) | Method for enhancing energy levels and reducing the effects of stress using nutraceutical formulations | |
US20150202181A1 (en) | Method of and compounds for the reduction of alcoholic hangover | |
EP1973425B1 (fr) | Utilisation nouvelle d'une composition alimentaire a usage humain ou veterinaire pauvre en polyamines pour la realisation d'un aliment therapeutique | |
FR3007986A1 (fr) | Medicament destine a lutter contre l'infertilite et la sous-fertilite en particulier dans le cadre d'une sous fertilite ou infertilite metabolique | |
FR2991181A1 (fr) | Composition pharmaceutique ou dietetique pour inhiber l'absorption intestinale du sucre et utilisable pour soigner le syndrome metabolique |